Trial Profile
Comparison of Oral Thiazides vs Intravenous Thiazides vs Tolvaptan in Combination With Loop Diuretics for Diuretic Resistant Decompensated Heart Failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Nov 2019
Price :
$35
*
At a glance
- Drugs Chlorothiazide (Primary) ; Tolvaptan (Primary) ; Metolazone
- Indications Hypervolaemia
- Focus Therapeutic Use
- 09 Jan 2019 Status changed from active, no longer recruiting to completed.
- 28 Sep 2018 Planned End Date changed from 1 May 2019 to 31 Oct 2018.
- 28 Sep 2018 Status changed from recruiting to active, no longer recruiting.